nemoj Zlikovac Ekonomski triple therapy after pci 6 months Mržnja potok Pogodi
Dapt Review
Antithrombotic therapy after pci in atrial fibrillation 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the
RE-DUAL PCI™ vs PIONEER AF-PCI™
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect
Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy | ECR Journal
Antithrombotic therapy in patients with mechanical valve prosthesis... | Download Scientific Diagram
Antithrombotic therapy after an ACS in atrial fibrillation patients... | Download Scientific Diagram
Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and after... 🧐 and finally (N)OAC alone! #
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Repor
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - ScienceDirect
Duration of triple therapy in patients requiring oral
JCM | Free Full-Text | Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study | HTML
Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary Results of the AUGUSTUS Trial - American College of Cardiology
British Cardiovascular Society
Dual antiplatelet therapy for secondary prevention of coronary artery disease | Open Heart
Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology
JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines | HTML
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.,The Lancet - X-MOL